Previous 10 | Next 10 |
home / stock / cansf / cansf news
2024-03-29 09:10:30 ET More on Willow Biosciences Financial information for Willow Biosciences Read the full article on Seeking Alpha For further details see: Willow Biosciences GAAP EPS of -C$0.10, revenue of C$1.17M
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF Canada NewsWire Completed the reorganization of the Company during 2023 with all lab operations now located in the Sunnyvale, California Record...
WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC Canada NewsWire CALGARY, AB , Feb. 29, 2024 /CNW/ - Willow Biosciences Inc. (" Willow " or the " Company ") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology c...
WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS Canada NewsWire Investment further validates Willow's technology for the development and sustainable manufacture of natural ingredients Additional capital will ...
WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT Canada NewsWire SUNNYVALE, Calif. , Jan. 31, 2024 /CNW/ - Willow Biosciences Inc. ...
WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS Canada NewsWire SUNNYVALE, Calif. , Jan. 16, 2024 /CNW/ - Willow Biosciences Inc. (" Willow ") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnol...
WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023 Canada NewsWire Estimated FY 2023 revenues in excess of $1.3 million is a record year for the Company Anticipate closing at least three new partnership development agreements including one...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share a significant development. The company has unveiled a noteworthy partnership with a Nasdaq-listed biopharmaceutical company, with a shared objective of forging precise and efficient manufacturi...
WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS Canada NewsWire Program brings immediate R&D revenue and first commercial supply revenue as early as 2024 ...
WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Canada NewsWire Record revenues for the third quarter and the nine months ended September 30, 2023 Patent application filed for a process to produce corticosteroids at an ...
News, Short Squeeze, Breakout and More Instantly...
Makena Resources Inc Company Name:
CANSF Stock Symbol:
OTCMKTS Market:
WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Canada NewsWire Company continues to advance its corticosteroid production platform and anticipates signing a large strategic partnership in Q2 2024 Signed two new program agr...
Willow Biosciences Inc., (OTC: CANSF) a frontrunner in biotech innovations for sustainable ingredient production, reported its financial and o...
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF Canada NewsWire Completed the reorganization of the Company during 2023 with all lab operations now located in the Sunnyvale, California Record...